{"meta":{"query_hash":"8a888064ae0e","filters":{"venue":"Hematologic malignancies"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8a888064ae0e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Hematologic+malignancies"},"results":[{"id":"W2127646700","doi":"10.1007/978-3-319-12505-3_24","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2014,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Internal medicine; Malignancy; Lung cancer; Oncology; Relative risk; Population; Absolute risk reduction; Radiation therapy","score_opus":0.01940116088779189,"score_gpt":0.23645098463569467,"score_spread":0.21704982374790277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127646700","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0213796,0.33547825,0.0053081866,0.028083079,0.0066988785,0.00004236186,0.0008600903,0.0002021613,0.6019475],"genre_scores_gemma":[0.14997192,0.28286678,0.004725062,0.013094616,0.009423391,0.000079743906,0.0011402635,0.00014997195,0.53854823],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999093,0.000022197104,0.0000045301936,0.000011079216,0.000042488027,0.000010477073],"domain_scores_gemma":[0.9998055,0.00012336273,0.000020752723,0.000006108398,0.000022404187,0.000021925807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018732851,0.00019921237,0.00023185833,0.0002764208,0.00020185286,0.00061931816,0.00024799022,0.0005230677,0.015796766],"category_scores_gemma":[0.0009367611,0.000083227984,0.0002493837,0.00024411129,0.00012683195,0.0004698083,0.00029315279,0.001061713,0.0020053668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007293809,0.00012022224,0.007175947,0.0004861489,0.00004369127,0.0018274826,0.00044648902,0.00088656764,0.0005550544,0.031783246,0.337928,0.61867416],"study_design_scores_gemma":[0.00001349042,0.00016506213,0.021474965,0.0015874348,0.00004860534,0.018242586,0.0003891382,0.00054352684,0.0005082764,0.030801162,0.926201,0.000024716346],"about_ca_topic_score_codex":0.0016680348,"about_ca_topic_score_gemma":0.0048560556,"teacher_disagreement_score":0.015796766,"about_ca_system_score_codex":0.000543884,"about_ca_system_score_gemma":0.0005662185,"threshold_uncertainty_score":0.05284542},"labels":[],"label_agreement":null},{"id":"W3094050214","doi":"10.1007/978-3-030-57317-1_2","title":"Antibacterial and Antiparasitic Prophylaxis","year":2020,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hematological malignancy; Intensive care medicine; Antimicrobial; Immunosuppression; Mortality rate; Adverse effect; Internal medicine","score_opus":0.028139573608117377,"score_gpt":0.253014325127207,"score_spread":0.22487475151908964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094050214","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005795498,0.09629,0.0033910281,0.0032177093,0.0044845706,0.000049501956,0.0001772446,0.00016471159,0.8916458],"genre_scores_gemma":[0.0020349326,0.038332168,0.0023518377,0.0029620621,0.0016209683,0.000039906765,0.00012398674,0.00007057165,0.9524636],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998727,0.000028297693,0.00000568877,0.000013055671,0.00006723115,0.000013023153],"domain_scores_gemma":[0.99988306,0.00006208177,0.000008392764,0.000008327197,0.000023934746,0.000014171647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022776905,0.00070801977,0.00040230263,0.0010175083,0.00045476004,0.0013620269,0.00054213766,0.0010064485,0.061533652],"category_scores_gemma":[0.00044713783,0.00018949233,0.00026692008,0.0007233673,0.00042168645,0.0011143496,0.0007827068,0.0019833199,0.029818404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026171396,0.00011708865,0.00008679559,0.0004562982,0.0000052636683,0.00025225256,0.00016194009,0.0003788329,0.0012371292,0.048943713,0.5083736,0.4399609],"study_design_scores_gemma":[0.0000016527307,0.000010973098,0.0000900178,0.00013772192,0.0000016771907,0.0002991322,0.000019428488,0.000046980305,0.00011492105,0.0045815087,0.9946937,0.000002287425],"about_ca_topic_score_codex":0.0010545307,"about_ca_topic_score_gemma":0.004654224,"teacher_disagreement_score":0.061533652,"about_ca_system_score_codex":0.0005468136,"about_ca_system_score_gemma":0.00061812456,"threshold_uncertainty_score":0.2058506},"labels":[],"label_agreement":null},{"id":"W4233452951","doi":"10.1007/978-3-030-32482-7_26","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2020,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hodgkin lymphoma; Medicine; Malignancy; Lymphoma; Oncology; Internal medicine","score_opus":0.02560708882478763,"score_gpt":0.23870812350478146,"score_spread":0.21310103467999383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233452951","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031582218,0.21296097,0.0029882442,0.015968537,0.004029529,0.000038767794,0.00089295616,0.00016442836,0.7313744],"genre_scores_gemma":[0.17740664,0.16278765,0.0024294006,0.0069313035,0.0063174157,0.000061138766,0.0010112126,0.000109392124,0.6429459],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999918,0.000020917083,0.0000033325887,0.000008284325,0.00003886407,0.000010625626],"domain_scores_gemma":[0.9997484,0.00016299916,0.000030240855,0.000007715865,0.000022068882,0.000028513752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016176607,0.00018595411,0.00021648625,0.00025109365,0.0002086693,0.0006176323,0.00023574597,0.0004757126,0.021809433],"category_scores_gemma":[0.00084703165,0.000077581964,0.00025316264,0.00027603997,0.00009426519,0.00037208534,0.00026734054,0.0008238103,0.002177478],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015242632,0.00021641867,0.018019361,0.0005846052,0.00005967427,0.0030221876,0.0005280219,0.0012727021,0.0008244794,0.02494481,0.32483432,0.625541],"study_design_scores_gemma":[0.000019045488,0.0004085753,0.060649708,0.0014576735,0.00007627355,0.028834451,0.0005309413,0.00087144814,0.000663198,0.02077347,0.88568884,0.00002638134],"about_ca_topic_score_codex":0.0015837777,"about_ca_topic_score_gemma":0.0054860036,"teacher_disagreement_score":0.021809433,"about_ca_system_score_codex":0.00047174783,"about_ca_system_score_gemma":0.00045035378,"threshold_uncertainty_score":0.07295978},"labels":[],"label_agreement":null}]}